TRV GP VI, LLC — Form 4 insider transactions

TRV GP VI, LLC — Full 13F portfolio →

Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.

Transaction date Activity Security Shares Price Total Filing
2026-10-30 Award Rapport Therapeutics, Inc. 1,190,476 $21.00 $24,999,996 SEC filing
2026-10-30 Award Rapport Therapeutics, Inc. 238,095 $21.00 $4,999,995 SEC filing
2026-08-12 Sell Septerna, Inc. 141 $51.08 $7,202 SEC filing
2026-08-12 Sell Septerna, Inc. 147,059 $50.27 $7,392,656 SEC filing
2026-05-26 Sell Rapport Therapeutics, Inc. 18,572 $40.05 $743,753 SEC filing
2026-05-11 Sell Rapport Therapeutics, Inc. 133,618 $40.24 $5,377,323 SEC filing
2026-05-08 Sell Rapport Therapeutics, Inc. 5,018 $40.31 $202,256 SEC filing
2026-05-07 Sell Rapport Therapeutics, Inc. 271,495 $40.12 $10,892,651 SEC filing
2026-04-17 Sell Rapport Therapeutics, Inc. 426,005 $40.32 $17,175,244 SEC filing

How Form 4 differs from 13F

13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.

All insider transactions →